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surgical history, ophthalmic medications, visual acuity, visual
ﬁeld parameters, and intraocular pressures. Economic data,
including physician visits (ophthalmologist/optometrist), diag-
nostic and monitoring tests, glaucoma medications, medical and
surgical procedures, and specialized glaucoma-related services,
were obtained from patient-level billing and reimbursement
records. Specialized LVC services collected via the chart review
for clinical and economic analysis included utilization of low-
vision devices (e.g., CCTV and magnifying devices), patient 
education and counseling for lifestyle modiﬁcations (e.g., glare
strategies and mobility training), and social/support services.
RESULTS: Of the 61 patients reviewed, 42% were male. The
mean age of the sample cohort was 75 years (minimum 33 years
to a maximum of 93 years). Of the 28 patients with applicable
data, 54% had a family history of glaucoma. Comorbid condi-
tions among the sample patients were hypertension (47%) and
diabetes (12%). The breakdown of payment type was 56%
Medicare and 21% Medicaid. At the same time, 33% of patients
had private coverage and 8% paid for their services out-of-
pocket. Mean direct cost of care was $1960 per patient during
the ﬁrst year of LVC, with 22.6% attributable to LVC. CON-
CLUSIONS: LVC contributed to the healthcare utilization and
direct costs of treating end-stage glaucoma patients.
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OBJECTIVES: To examine blindness-related comorbidities in a
Medicare population with primary open angle glaucoma
(POAG), speciﬁcally fractures (including hip, femoral, and ver-
tebral fractures) and depression (including several types of
depressive/neurotic conditions), and their association with being
diagnosed as blind. A secondary objective is to examine the total
Medicare-related healthcare spending between non-blind and
blind glaucoma patients relative to comorbidities. METHODS:
The data source was a Medicare 5% Sample of 1998 Glaucoma
Patients with and without blindness (n = 70,060). Odds ratios
(OR) were created from the annual prevalence rates of fractures
and depression between blind and non-blind groups. Multiple
propensity scoring methods were used to account for selection
bias in those patients coded for blindness. Comparisons were
conducted between blind (cases) and non-blind (controls) groups
before and after matching cases to controls by propensity score.
Matched and unmatched results were also stratiﬁed by age, sex,
and Charlson Comorbidity Index scores. Medicare reimburse-
ments were compared between groups using non-parametric sta-
tistical methods. RESULTS: The overall matched odds ratios for
depression and depressive disorders in the blind group were 1.88
(95% CI: 1.08–3.28) and 1.63 (95% CI: 1.05–2.52), respec-
tively. Hip fractures had a signiﬁcant OR 4.86, (95% CI:
1.158–20.36) speciﬁcally in the unmatched 65–69 year-old
cohort but not in the matched. Total age-adjusted non-eye
related Medicare costs were signiﬁcantly greater in the blind
group ($2510 vs. $1784). The mean annual cost for depression
related procedures/visits for those diagnosed with depression was
$411 in the blind group vs. $185 in the non-blind group. CON-
CLUSIONS: There is an association with being blind in a glau-
coma population and having a greater risk for depression and
fractures (in younger cohorts). The blind glaucoma population
has greater age-adjusted eye-related and total (non-eye-related)
Medicare costs than non-blind glaucoma subjects.
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OBJECTIVES: The non-medical costs of visual impairment to
individuals and the nation are largely unknown. Data produced
by state agencies are not relevant. Knowledge of these costs is
essential when allocating resources to therapeutic or preventa-
tive programs. METHODS: We analysed two representative
nation-wide surveys of 14,603 subjects living in institutions, and
16,945 in the community, with the object of documenting hand-
icap. Subjects were classiﬁed as blind (no light perception), low
vision (LV: loss of shape perception), or control. We also costed
the following items: family income, social allowances, devices,
home modiﬁcation, paid assistance, time spent by carers and
unmet needs. Next, we standardised item consumption on con-
founding factors, using logistic regression. Lastly, unit costs
attributable to visual impairment were estimated and compared
with the costs incurred by control subjects. Our economic stand-
point was that of society. RESULTS: The national non-medical
costs attributable to LV (9438€m; 14,659€m with unmet needs)
accounted for almost the entire costs of visual impairment
(10,749€m; 1630€2m with unmet needs). However, the average
annual cost/patient was 7826€ for LV (12,154€ with unmet
needs) versus 19,173€ for blindness (24,036€ with unmet needs).
Lost family income amounted to 4552€m and the carers’ burden
to 2525€m. In addition, 5080€m of social allowances were not
distributed because many blind people do not register. CON-
CLUSIONS: Indemniﬁcation of visual handicap should cover
total non-medical costs including the predominant unmet needs.
Thus strategies of resource allocation, intended to alleviate visual
impairment, should include all economic dimensions, extending
to non-medical items.
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OBJECTIVES: To estimate nursing time and costs attributable
to visual impairment from a questionnaire documenting activi-
ties of daily living (ADLs) in France. METHODS: 356,208 citi-
zens in the general community were selected at random. A
sub-sample of 16,945 subjects (blind, low vision and control)
was further selected randomly and interviewed. The ADL ques-
tionnaire was comprised of more than 30 items, including
washing, cooking, mobility, shopping, cleaning, etc. A factor
analysis was performed and six clusters were identiﬁed: hygiene
and meals; physical capacity; transport and housework; ability
to move; behavioral problems; and autonomy. Three levels of
dependency were predeﬁned for each cluster: none; subject
required partial help; subject required complete help. A subset
